Accelerated intermittent theta burst as a substitute for patients needing electroconvulsive therapy during the COVID-19 pandemic: study protocol for an open-label clinical trial
View ORCID ProfileDaniel M. Blumberger, Zafiris J. Daskalakis, Fidel Vila-Rodriguez, David Boivin-Lafleur, Michelle S. Goodman, Tyler Kaster, Yuliya Knyahnytska, Gerasimos Konstantinou, Alisson P. Trevizol, Daphne Voineskos, Cory R. Weissman, Jonathan Downar
doi: https://doi.org/10.1101/2020.12.15.20248260
Daniel M. Blumberger
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Zafiris J. Daskalakis
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
3Department of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92161, USA
Fidel Vila-Rodriguez
4Non-Invasive Neurostimulation Therapies Laboratory, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada
David Boivin-Lafleur
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Michelle S. Goodman
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
Tyler Kaster
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Yuliya Knyahnytska
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Gerasimos Konstantinou
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Alisson P. Trevizol
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Daphne Voineskos
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Cory R. Weissman
1Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, 1001 Queen St West, Toronto, ON M6J 1H4, Canada
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
Jonathan Downar
2Department of Psychiatry, University of Toronto, 563 Spadina Crescent, Toronto, ON M5S 2 J7, Canada
5Krembil Research Institute and Centre for Mental Health, University Health Network, 60 Leonard Ave, Toronto, ON M5T 0S8, Canada
Article usage
Posted December 17, 2020.
Accelerated intermittent theta burst as a substitute for patients needing electroconvulsive therapy during the COVID-19 pandemic: study protocol for an open-label clinical trial
Daniel M. Blumberger, Zafiris J. Daskalakis, Fidel Vila-Rodriguez, David Boivin-Lafleur, Michelle S. Goodman, Tyler Kaster, Yuliya Knyahnytska, Gerasimos Konstantinou, Alisson P. Trevizol, Daphne Voineskos, Cory R. Weissman, Jonathan Downar
medRxiv 2020.12.15.20248260; doi: https://doi.org/10.1101/2020.12.15.20248260
Accelerated intermittent theta burst as a substitute for patients needing electroconvulsive therapy during the COVID-19 pandemic: study protocol for an open-label clinical trial
Daniel M. Blumberger, Zafiris J. Daskalakis, Fidel Vila-Rodriguez, David Boivin-Lafleur, Michelle S. Goodman, Tyler Kaster, Yuliya Knyahnytska, Gerasimos Konstantinou, Alisson P. Trevizol, Daphne Voineskos, Cory R. Weissman, Jonathan Downar
medRxiv 2020.12.15.20248260; doi: https://doi.org/10.1101/2020.12.15.20248260
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2780)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12430)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4297)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4072)
- Nursing (218)
- Nutrition (603)
- Oncology (2154)
- Ophthalmology (608)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6677)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)